Literature DB >> 12965214

Methylglyoxal modifies heat shock protein 27 in glomerular mesangial cells.

Anoop K Padival1, John W Crabb, Ram H Nagaraj.   

Abstract

Methylglyoxal (MGO) can modify tissue proteins through the Maillard reaction, resulting in advanced glycation end products (AGEs), which can alter protein structure and functions. Several MGO-derived AGEs have been described, including argpyrimidine, a fluorescent product of the MGO reaction with arginine residues. We detected significant amount of argpyrimidine in rat kidney mesangial cells cultured in media containing high concentrations of glucose. Heat shock protein 27 (Hsp27) was identified by liquid chromatography tandem mass spectrometry as a major anti-argpyrimidine immunoreactive protein. We confirmed this finding by reciprocal co-immunoprecipitation and by Western analysis. Diabetic rats contained more argpyrimidine-modified glomerular Hsp27 than non-diabetic animals. Additional studies showed that MGO-induced modification of Hsp27 decreased its binding to cytochrome c. Our results suggest that Hsp27 is a major target for MGO modification in mesangial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965214     DOI: 10.1016/s0014-5793(03)00874-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Heat shock protein 27: its potential role in vascular disease.

Authors:  Gordon Ferns; Sedigheh Shams; Shahida Shafi
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

Review 2.  Small heat shock proteins in ageing and age-related diseases.

Authors:  Nikolaos Charmpilas; Emmanouil Kyriakakis; Nektarios Tavernarakis
Journal:  Cell Stress Chaperones       Date:  2017-01-10       Impact factor: 3.667

3.  Is the small heat shock protein HspB1 (Hsp27) a real and predominant target of methylglyoxal modification?

Authors:  Maria V Sudnitsyna; Nikolai B Gusev
Journal:  Cell Stress Chaperones       Date:  2019-02-12       Impact factor: 3.667

4.  Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function.

Authors:  Antonia G Miller; Genevieve Tan; Katrina J Binger; Raelene J Pickering; Merlin C Thomas; Ram H Nagaraj; Mark E Cooper; Jennifer L Wilkinson-Berka
Journal:  Diabetes       Date:  2010-09-17       Impact factor: 9.461

Review 5.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

6.  GLO1 overexpression in human malignant melanoma.

Authors:  Warner B Bair; Christopher M Cabello; Koji Uchida; Alexandra S Bause; Georg T Wondrak
Journal:  Melanoma Res       Date:  2010-04       Impact factor: 3.599

Review 7.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

8.  Protein modification by dicarbonyl molecular species in neurodegenerative diseases.

Authors:  Wesley M Williams; Aaron Weinberg; Mark A Smith
Journal:  J Amino Acids       Date:  2011-03-14

9.  Hydroimidazolone modification of the conserved Arg12 in small heat shock proteins: studies on the structure and chaperone function using mutant mimics.

Authors:  Ram H Nagaraj; Alok Kumar Panda; Shilpa Shanthakumar; Puttur Santhoshkumar; NagaRekha Pasupuleti; Benlian Wang; Ashis Biswas
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

10.  Cytoplasmic and nuclear anti-apoptotic roles of αB-crystallin in retinal pigment epithelial cells.

Authors:  Woo Jin Jeong; Jee Hyun Rho; Young Geol Yoon; Seung Hee Yoo; Na Young Jeong; Won Yeol Ryu; Hee Bae Ahn; Woo Chan Park; Sae Heun Rho; Hee Seong Yoon; Yung Hyun Choi; Young Hyun Yoo
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.